Best Healthcare Market Research Companies in Latin America

 Latin America (LatAm) is an increasingly strategic region for healthcare and life sciences organizations. Driven by shifting demographics, a growing chronic-disease burden, rising healthcare expenditure, and continued consolidation across public and private systems, the region presents both opportunities and complexity. For pharmaceutical companies, medical device manufacturers, and investors evaluating entry or expansion, partnering with a knowledgeable, regionally experienced market-research provider is essential.

Below is a curated list of top healthcare market-research and intelligence firms serving Latin America—selected for their regional presence, healthcare-domain specialization, and relevance for pharma, MedTech, and life sciences executives.

1. Americas Market Intelligence (AMI)

AMI’s dedicated Latin America healthcare practice focuses on medical devices, pharmaceuticals, and healthcare services. The firm reports having completed over 400 studies across the region, covering medical devices, pharmaceuticals, import/export flows, clinical research, and distribution networks.

Why it stands out:
AMI combines a strong regional footprint with deep, healthcare-specific data assets—such as robust device and consumable tracking. Its expertise in high-stakes LatAm market-entry and expansion strategies makes it a trusted partner for companies targeting Brazil, Mexico, Argentina, Colombia, and Chile.

Key services:

• Market sizing and forecasting
  
  

• Channel and distribution mapping
  
  

• Physician insights and qualitative research
  
  

• Competitive intelligence
  
  

• Import/export and regulatory analytics
  
  

Ideal for:
Pharma, MedTech, and diagnostics companies seeking robust LatAm-specific datasets and strategic segmentation to inform go-to-market decisions.

2. InVeritas Research

InVeritas is a full-service market-research company with a strong Latin America division specializing in healthcare, pharmaceuticals, and medical devices. The firm maintains a proprietary panel of 400,000+ physicians and 250,000+ allied health professionals across Latin America and neighboring markets.

Why it stands out:
InVeritas excels in fieldwork-intensive research across the region, offering F2F interviewing, CATI, CAPI, and central-location testing. They also have strong reach into senior HCPs and KOLs within Latin America, which is often challenging to secure.

Key services:

• Quantitative and qualitative healthcare research
  
  

• HCP recruitment for difficult-to-reach specialties
  
  

• Product usage and attitude studies
  
  

• Device and pharma concept testing
  
  

Ideal for:
Pharma and MedTech companies needing high-quality, locally executed primary research in Spanish and Portuguese-speaking markets—particularly for segmentation, positioning, and launch readiness.

3. 1Plus1 Research

1Plus1 Research is a regional specialist emphasizing digital-enabled healthcare research across Latin America. The company highlights access to 5 million+ global consumer and B2B panelists, including 500,000+ physicians covering 650+ medical specialties.

Why it stands out:
Their strength lies in advanced digital research—such as online communities, agile surveys, remote ethnography, and usability testing. These capabilities enable rapid, flexible insight generation in a region where digital transformation is accelerating but uneven.

Key services:

• Online surveys and digital ethnography
  
  

• Usability and UX research for devices and platforms
  
  

• HCP and patient insights
  
  

• Brand and performance tracking
  
  

Ideal for:
Organizations seeking fast, digital-first insights for product development, patient experience research, device usability testing, or brand tracking across Latin America.

4. DelveInsight

DelveInsight is a global life sciences market-research and consulting firm offering deep expertise in pharmaceuticals, biotech, and healthcare analytics. While not limited to Latin America, the firm supports regional strategy, competitive intelligence, and market assessments across emerging markets, including LatAm.

Why it stands out:
DelveInsight brings strong global life sciences expertise, extensive therapeutic coverage, and a large repository of syndicated reports. Its customized consulting solutions—spanning forecasting, epidemiology, market-entry, and CI—make it a valuable partner for companies requiring global depth with local applicability.

Key services:

• Syndicated reports
  
  

• Custom consulting and market-entry assessments
  
  

• Epidemiology and forecasting
  
  

• Competitive and pipeline intelligence
  
  

• Licensing and opportunity evaluation
  
  

Ideal for:
Pharma and biotech teams seeking a global life-sciences–focused partner capable of supporting Latin America strategy, forecasting, and competitive landscape assessments.

5. Trinity Life Sciences

Trinity Life Sciences positions itself as a strategic research and consulting partner with robust healthcare expertise in Latin America. Their regional offerings focus on market research, forecasting, commercialization, and launch excellence.

Why it stands out:
Trinity provides full lifecycle support—from opportunity assessment and forecasting to pricing, access, and commercialization—making it ideal for companies planning significant launches or portfolio expansion in the region.

Key services:

• New product planning
  
  

• Brand and marketing strategy
  
  

• Evidence strategy and HEOR support
  
  

• Pricing and market access research
  
  

• Forecasting and launch excellence
  
  

• Competitive intelligence
  
  

Ideal for:
Mid-size to large pharma and MedTech companies with complex LatAm launches requiring strategic planning beyond traditional market research.

Choosing the Right Partner: Key Considerations

When evaluating market-research providers for Latin America, healthcare leaders should prioritize the following:

1. Regional footprint and language capability

Latin America is diverse—Brazil (Portuguese) differs significantly from Spanish-speaking markets. Local fieldwork capability and cultural fluency are essential.

2. Healthcare-domain specialization

Prioritize firms with proven experience in pharmaceuticals, MedTech, diagnostics, or payer research—not generic consumer insights providers.

3. Strong primary-research capability

Access to HCPs, patients, payers, and KOLs across LatAm drives richer, more actionable insights.

4. Segment-specific expertise

For pharma and MedTech, capabilities in epidemiology, launch modeling, pricing, access, and device UX are increasingly critical.

5. Forecasting and strategic depth

Investors and strategy teams require partners who can interpret future market dynamics, regulatory shifts, and reimbursement trends.

6. Cultural and linguistic adaptability

Insights must be localized and culturally relevant to drive actionable strategy.

7. Bespoke vs. syndicated solutions

Companies should clarify whether they need customized studies or syndicated reports based on budget and depth of requirement.

Why Latin America Matters for Healthcare Market Research

Latin America’s healthcare sector is entering a growth phase:

• The LatAm pharmaceutical market is estimated at ~USD 74.6 billion in 2024, with a forecasted CAGR of ~5.4% through 2030.
  
  

• The LatAm CRO (Contract Research Organization) market was valued at USD 4.57 billion in 2023, projected to reach ~USD 6.77 billion by 2030 at a ~5.8% CAGR.
  
  

Such growth increases demand for high-quality regional intelligence on:

• Market access and reimbursement
  
  

• Regulatory complexity
  
  

• Device and technology adoption
  
  

• KOL and clinician behavior
  
  

• Competitive dynamics

How to Effectively Engage a LatAm Market-Research Partner

1. Define a clear scope

Examples include:

• Market-entry assessment in Brazil and Mexico for a cardiovascular device
  
  

• Physician usage and patient journey mapping in Colombia for an oncology therapy
  
  

2. Ensure localization

Research execution varies dramatically between São Paulo, Mexico City, Bogotá, Buenos Aires, and Santiago. Verify local panel access and linguistic capabilities.

3. Align deliverables and outputs

Specify expectations—market sizing, competitive benchmarks, pricing/access landscapes, patient/HCP insights, etc.

4. Build strategic implications into the project

Beyond data collection, ensure findings connect to real-world decisions such as launch timing, partner selection, and access strategy.

5. Validate regulatory understanding

LatAm markets vary widely in regulatory and reimbursement structures; choose a firm with proven local competency.

Conclusion

Latin America offers growing opportunities for healthcare, pharma, and MedTech companies—but only with the right market intelligence. Firms such as AMI, InVeritas, 1Plus1 Research, DelveInsight, and Trinity Life Sciences provide a mix of regional expertise, healthcare specialization, and strategic insight to navigate this complex environment.

By selecting a market-research partner aligned to your objectives—whether market entry, launch planning, forecasting, or patient and physician insights—you can significantly strengthen your Latin America strategy and position your organization for long-term success.